Home » Newsletters » BioWorld

BioWorld

Sep. 27, 1991

View Archived Issues

ANALYST DOWNPLAYS GM-CSF PATENT NEWS

CHIRON/CETUS MERGER PASSES FTC DEADLINE

CENTOCOR RAISES SIZE OF DEBENTURES

EPITOPE GETS GRANT FOR HIV TEST

MGI GETS RIGHTS TO PILOCARPINE MOUTHWASH

HEMACARE EXTENDS WARRANT EXPIRATION

OXFORD COMPLETES $8M FINANCING

SBIR GRANTED FOR AMYLIN MABS

FDA PANEL RECOMMENDATION SPURS CHIRON

SUITS OPPOSE GI MERGER WITH AHP

COMBINATION TEST APPROVED FOR HIV-1, 2

MULTIDRUG STRATEGY TO COMBAT AIDS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...